Pickering L K, Gearhart P
Antimicrob Agents Chemother. 1979 Apr;15(4):592-6. doi: 10.1128/AAC.15.4.592.
An aminoglycoside antibiotic and carbenicillin or ticarcillin are widely used in the treatment of patients with gram-negative bacillus infections. This study evaluated the effect of time upon in vitro interaction between mixtures of four aminoglycosides at two concentrations with carbenicillin or ticarcillin at four concentrations. By linear regression analysis, the inactivation of each aminoglycoside was shown to be directly proportional to the concentration of carbenicillin (P < 0.001). Inactivation was significantly (P < 0.01) greater for gentamicin and tobramycin than for amikacin or netilmicin at all carbenicillin concentrations. At carbenicillin concentrations of 300 and 600 mug/ml, significantly (P < 0.005) less inactivation of amikacin occurred when compared to netilmicin. Ticarcillin produced a significant (P < 0.025) inactivation of gentamicin and tobramycin, with inactivation being directly proportional to ticarcillin concentration. No inactivation of amikacin or netilmicin activity occurred unless the ticarcillin concentration was 600 mug/ml. No significant change in aminoglycoside activity occurred when stored with ticarcillin or carbenicillin at concentrations ranging from 100 to 600 mug/ml at -70 degrees C for 56 days. When an aminoglycoside and carbenicillin or ticarcillin are indicated in patients with renal failure, this study supports the use of ticarcillin with either amikacin or netilmicin.
一种氨基糖苷类抗生素与羧苄西林或替卡西林被广泛用于治疗革兰氏阴性杆菌感染患者。本研究评估了时间对两种浓度的四种氨基糖苷类药物与四种浓度的羧苄西林或替卡西林混合物体外相互作用的影响。通过线性回归分析,显示每种氨基糖苷类药物的失活与羧苄西林浓度成正比(P < 0.001)。在所有羧苄西林浓度下,庆大霉素和妥布霉素的失活显著(P < 0.01)大于阿米卡星或奈替米星。在羧苄西林浓度为300和600μg/ml时,与奈替米星相比,阿米卡星的失活显著(P < 0.005)减少。替卡西林使庆大霉素和妥布霉素显著(P < 0.025)失活,失活与替卡西林浓度成正比。除非替卡西林浓度为600μg/ml,否则阿米卡星或奈替米星活性不会失活。当在-70℃下与浓度为100至600μg/ml的替卡西林或羧苄西林储存56天时,氨基糖苷类药物活性无显著变化。当肾衰竭患者需要使用氨基糖苷类抗生素和羧苄西林或替卡西林时,本研究支持将替卡西林与阿米卡星或奈替米星联合使用。